首页
订购/客服:400-666-5481

RBN-2397

    
98.80%

源叶(MedMol)
S89684 一键复制产品信息
2381037-82-5
C20H23F6N7O3
523.43
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89684-5mg促销
98.80%

¥1500.00 ¥1200.00

5 - - - -
S89684-10mg促销
98.80%

¥2500.00 ¥2000.00

6 - - - -
S89684-25mg促销
98.80%

¥5000.00 ¥4000.00

5 - - - -
S89684-100mg促销
≥98%

¥13700.00 ¥10900.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: RBN-2397 is a potent, accross species and orally active NAD+ competitive inhibitor of PARP7 (IC50<3 nM). RBN-2397 selectively binds to PARP7 (Kd=0.001 μM) and restores IFN signaling. RBN-2397 has the potential for the study of advanced or metastatic solid tumors
靶点: PARP-7:3 nM (IC50); PARP-7:1 nM (Kd);PARP
体外研究: RBN-2397 (0.0001-100 μM; 24 hours) inhibits cells? proliferation with an IC50 value of 20 nM in NCI-H1373 lung cancer cells. RBN-2397 (0.4 nM-1 μM; 24 hours) shows a restoration of type I IFN response by an increase in STAT1 phosphorylation as a dose-dependent manner in NCI-H1373 human lung cancer cells. RBN-2397 (0.0001-1 μM; 24 hours) inhibits cell MARylation in a cell biochemial assay with an EC50 value of 1 nM. Cell Proliferation Assay Cell Line: NCI-H1373 lung cancer cells Concentration: 0.0001 μM; 0.001 μM; 0.001 μM; 0.1 μM; 1 μM; 10 μM; 100 μM Incubation Time: 24 hours Result: Blocked cell proliferation. Western Blot Analysis Cell Line: NCI-H1373 lung cancer cells Concentration: 0.4 nM-1 μM Incubation Time: 24 hours Result: Increased p-STAT1 protein expression.
体内研究: RBN-2397 (oral administration; 3-100 mg/kg; once daily; 24-32 days) induces tumor-specific adaptive immune memory in CT26 syngeneic model with durable complete responses in CT26 tumor-bearing BALB/c mice. RBN-2397 (oral administration; 3-100 mg/kg; once daily; 32 days) causes complete regressions at the dose 100 mg/kg and exerts a dose-dependent effects on tumor growth at dose levels of ≥30 mg/kg. The half-life (t1/2) of RBN-2397 in vivo is 325 mins. Animal Model: CB17 SCID mice with NCI-H1373 xenografts Dosage: 3 mg/kg, 10mg/kg, 30 mg/kg, 100 mg/kg Administration: Oral administration; once daily; 24-32 days Result: Decreased tumor volume and exerted anti-tumor effects.
参考文献: 1. RBN-2397-Inhibiting PARP7, a Key monoPARP Cancer Dependency 2. Melissa Vasbinder, et al. RBN-2397: A First-in-Class PARP7 Inhibitor Targeting a Newly Discovered Cancer Vulnerability in Stress-Signaling Pathways.
溶解性: Soluble  in  DMSO
保存条件: 2-8℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.91 ml 9.552 ml 19.105 ml
5 mM 0.382 ml 1.91 ml 3.821 ml
10 mM 0.191 ml 0.955 ml 1.91 ml
50 mM 0.038 ml 0.191 ml 0.382 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×